Related Experiment Video
Updated: Aug 21, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Pheochromocytoma: diagnosis and management update
William M Manger1, Graeme Eisenhofer
1New York University Medical Center and National Hypertension Association, 324 East 30th Street, New York, NY 10016, USA. nathypertension@aol
Abstract:
Pheochromocytoma is a rare but extremely treacherous neuroendocrine tumor causing manifestations by secreting catecholamines into the circulation. It is usually fatal if unrecognized. Manifestations can mimic many diseases and cause erroneous diagnoses. Approximately 15% are malignant, 18% extra-adrenal, and 20% familial. Plasma or urinary metanephrines are approximately 98% sensitive for detecting pheochromocytomas. They can be localized by MRI and CT; (131)I- and (123)I-metaiodobenzylguanidine (MIBG) are highly specific and 81% to 90% sensitive, respectively. Suspect pheochromocytoma in patients with sustained or paroxysmal hypertension or in normotensives having manifestations of hypercatecholaminemia. Surgical removal is usually curative; chemotherapy and radiotherapy are palliative for malignant pheochromocytomas.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cardiomyopathy VII: Pre and Post Operative Nursing Management